Company: KITTW
Filing Date: 2025-10-24
Form Type: 424B3
Source: 0001849820-25-000253
Chunk: 15

Company: Nauticus Robotics, Inc.
Filing Date: 2025-10-24
Form: 424B3
Chunk 15
---
 timing, prices, and number of shares of common stock sold in this offering. In addition, subject to the final determination by our board of directors or any restrictions we may place in any applicable placement notice, there is no minimum or maximum sales price for shares to be sold in this offering. Investors may experience a decline in the value of the shares they purchase in this offering as a result of sales made at prices lower than the prices they paid.

Outstanding options and warrants are exercisable for shares of our common stock. Additionally, we have previously issued preferred convertible stock, convertible debentures and convertible term loans. Any future exercise of such options or warrants, or conversion of such preferred convertible stock, convertible debentures or convertible term loans, would increase the number of shares of our common stock eligible for future resale in the public market and result in dilution to our stockholders.

We have outstanding options (currently, with 1,880 underlying shares) and warrants (currently, with 60,602 underlying shares), we have previously issued preferred convertible stock (currently, with 2,308,536 underlying shares), convertible debentures (currently, with 233,062 underlying shares) and convertible term loans (currently, with 630,225 underlying shares). Any future exercise, conversion, or release of such securities would increase the number of shares of our common stock eligible for future resale in the public market and result in dilution to our stockholders. Sales of substantial numbers of shares of our common stock in the public market could materially and adversely affect the market price of our common stock. Certain of our securities also contain anti-dilution and similar provisions that in the future may have the effect of increasing the amount of issued and outstanding shares of our common stock.

<div align='center'>S-9</div>

### USE OF PROCEEDS
We may issue and sell shares of our common stock having aggregate sales proceeds of up to $1,600,000 from time to time. Because there is no minimum offering amount required as a condition of this offering, the actual total public offering amount, commissions, and proceeds to us, if any, are not determinable at this time. There can be no assurance that we will sell any shares of our common stock under or fully utilize the Sales Agreement with Wainwright as a source of financing.

We will retain broad discretion over the use of the net proceeds to us from the sale of our common stock under this prospectus supplement, an investor will not have the opportunity to evaluate the economic